
The company has signed a multi-year contract with a leading global pharmaceutical company. This contract entails the development and supply of a portfolio of niche APIs over a period of 10 years, Hikal said in a regulatory filing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Rup3Q0
via
IFTTT
0 comments:
Post a Comment